These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4199834)

  • 41. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 42. [New possibilities in the management of venous perfusion disorders].
    Weitgasser H
    Z Haut Geschlechtskr; 1968 Feb; 43(4):153-8. PubMed ID: 4969940
    [No Abstract]   [Full Text] [Related]  

  • 43. [Electroencephalographic findings in cerebral vascular diseases in aged patients and their changes under the influence of sympatholytic (Hydergine) therapy].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    Riv Neurol; 1967; 37(3):231-50. PubMed ID: 4965103
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapeutic effects of hydergine in mental disorders in the involutional age].
    Bonasera N; Smorto M; Scialfa G
    Osp Psichiatr; 1968; 36(1):75-87. PubMed ID: 4988290
    [No Abstract]   [Full Text] [Related]  

  • 45. [Influence of hydergine in the vertebro-basilar vascular insufficiency syndrome of cervical origin].
    Sánchez Dueñas M
    Rev Esp Otoneurooftalmol Neurocir; 1970; 28(161):41-6. PubMed ID: 4999170
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hydergine in high doses in neurosurgery for the prevention of postoperative hemorrhagic complications].
    Torelli L; Zotti G
    Friuli Med; 1966; 21(3):379-89. PubMed ID: 4964695
    [No Abstract]   [Full Text] [Related]  

  • 47. [Combined treatment with hydergine and neuroleptics in mental disorders of old age].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1969; 3(3):327-32. PubMed ID: 4980081
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 49. [Vergebro-basilar insufficiency. Prevention of transient ischemic accidents with hydergine].
    Augustin P; Lechevalier B
    Therapeutique; 1970 May; 46(5):543-6. PubMed ID: 4988090
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical test using Brinaldix plus Hydergine].
    Elizalde JE
    Hospital (Rio J); 1967 Dec; 72(6):1941-2. PubMed ID: 4983683
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of hydergine in the psychiatric setting. Clinical study comprising 107 patients of the Hôpital Psychiatrique de Pierrefeu (Var)].
    Boutillier H; Bodilis A; Grégoire F
    Sem Ther; 1967 May; 43(5):300-4. PubMed ID: 4970731
    [No Abstract]   [Full Text] [Related]  

  • 52. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
    Ronge J; Dennler HJ
    Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of hydergine on the functional manifestations of encephalic vasomotricity].
    Memin Y; Rigal P
    Lyon Med; 1971 Jun; 225(11):1177-82. PubMed ID: 4997290
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative studies on prevention of thromboembolism using panthesin-hydergin].
    Schwalbe E; Fauner A
    Med Monatsschr; 1971 Apr; 25(4):185-8. PubMed ID: 4995458
    [No Abstract]   [Full Text] [Related]  

  • 55. Utilization of thioridazine combined with hydergine in the treatment of incipient mental disturbances in cerebral atherosclerosis.
    Predescu V; Ciurezu T; Nica S; Ionescu R; Tudorache D; Niţurad A; Oproiu L; Popovici I; Curelaru S; Roman I
    Rev Roum Neurol Psychiatr; 1974; 11(3):243-8. PubMed ID: 4211107
    [No Abstract]   [Full Text] [Related]  

  • 56. [Methods and problems of clinical psychopharmacology. Results of a double blind study with Medazepam and placebo in geriatirc psychiatry].
    Bergener M; Undeutsch D
    Arzneimittelforschung; 1968 Dec; 18(12):1563-6. PubMed ID: 4887291
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prevention of drepanocytic painful crises with hydergine].
    Cuisinier JC; Ducloux M; Lagarde B; Barbotin M; Darracq R
    Bull Soc Med Afr Noire Lang Fr; 1974; 19(2):168-72. PubMed ID: 4219596
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effects of the administration of the drug association: hydergine-thioridazine (HM 51), in the treatment of coronary angina].
    Martelli A; Melilla GN
    G Clin Med; 1968 Mar; 49(3):310-43. PubMed ID: 4985903
    [No Abstract]   [Full Text] [Related]  

  • 59. Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
    Petrie WM; Ban TA; Berney S; Fujimori M; Guy W; Ragheb M; Wilson WH; Schaffer JD
    J Clin Psychopharmacol; 1982 Apr; 2(2):122-6. PubMed ID: 7042770
    [No Abstract]   [Full Text] [Related]  

  • 60. [Analysis of the efficiency of Gerigoa-depot in a double-blind study].
    Jansen W
    Med Welt; 1976 Jul; 27(30):1446-7. PubMed ID: 785152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.